Eradicating neurodegenerative diseases
Abyssinia Biologics has raised $750K in total funding. The most recent round was Seed. The last funding was announced in January 2024.
Abyssinia Biologics's investors include Maine Technology Institute.
Abyssinia Biologics is headquartered in Boston, United States.
Eradicating neurodegenerative diseases
Abyssinia Biologics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Abyssinia Biologics — Funding & Investors." VCBacked, January 1, 2024, https://www.vcbacked.co/company/abyssinia-biologics. Accessed September 2, 2026.
VCBacked. (2024). Abyssinia Biologics — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/abyssinia-biologics
{{cite web |title=Abyssinia Biologics — Funding & Investors |url=https://www.vcbacked.co/company/abyssinia-biologics |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated